Thibault BAHOUGNE

Dr. Thibault BAHOUGNE


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Best Practice & Research Clinical Endocrinology & Metabolism
Verified
Journal Article
Closed access
VSValérie Simonneaux
Valérie Simonneaux
TBThibault BAHOUGNE
Thibault BAHOUGNE
EAEleni Angelopoulou
Eleni Angelopoulou

26 February 2020 in Endocrinology
Verified
Journal Article
Closed access
TBThibault BAHOUGNE
Thibault BAHOUGNE
MKMathilda Kretz
Mathilda Kretz
EAEleni Angelopoulou
Eleni Angelopoulou
NJNathalie Jeandidier
Nathalie Jeandidier
VSValérie Simonneaux
Valérie Simonneaux
In female mammals, cycles in reproductive function depend both on the biological clock synchronized to the light/dark cycle and on a balance between the negative and positive feedbacks of estradiol, whose concentration varies during oocyte maturation. In women, studies report that chronodisruptive environments such as shiftwork may impair fertility and gestational success. The objective of this study was to explore the effects of shifted light/dark cycles on both the robustness of the estrous cycles and the timing of the preovulatory luteinizing hormone (LH) surge in female mice. When mice were exposed to a single 10-hour phase advance or 10-hour phase delay, the occurrence and timing of the LH surge and estrous cyclicity were recovered at the third estrous cycle. By contrast, when mice were exposed to chronic shifts (successive rotations of 10-hoursour phase advances for 3 days followed by 10-hour phase delays for 4 days), they exhibited a severely impaired reproductive activity. Most mice had no preovulatory LH surge at the beginning of the chronic shifts. Furthermore, the gestational success of mice exposed to chronic shifts was reduced, because the number of pups was 2 times lower in shifted than in control mice. In conclusion, this study reports that exposure of female mice to a single phase shift has minor reproductive effects, whereas exposure to chronically disrupted light/dark cycles markedly impairs the occurrence of the preovulatory LH surge, leading to reduced fertility.

23 October 2019 in GeroScience
Verified
Journal Article
Closed access
PDF file
TBThibault BAHOUGNE
Thibault BAHOUGNE
EAEleni Angelopoulou
Eleni Angelopoulou
NJNathalie Jeandidier
Nathalie Jeandidier
VSValérie Simonneaux
Valérie Simonneaux

1 February 2017 in Endocrine-Related Cancer
Verified
Journal Article
Closed access
PDF file
TBThibault BAHOUGNE
Thibault BAHOUGNE
AIAlessio Imperiale
Alessio Imperiale
GAGerlinde Averous
Gerlinde Averous
GCGerard Chabrier
Gerard Chabrier
NBNelly Burnichon
Nelly Burnichon
LKLaurence Kessler
Laurence Kessler
Introduction: Early and accurate identification of recurrences in patients with aggressive paraganglioma (PGL) poses significant challenges. Moreover, the most appropriate therapeutic strategy for recurrent PGL remains to be established. Results: We report the case of 52-year-old man with a history of recurrent, sporadic, left retroperitoneal PGL that relapsed twice (at eight and nine years after the first surgical intervention). At the time of the second recurrence, 2-deoxy-2-[fluorine-18]fluoro-D-glucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated a pathologically increased tracer uptake in multiple nodular lesions (10−15 mm in size) located close to the remnant of the left renal pedicle and in the left lombar paravertebral region. Moreover, PET/CT showed a hypermetabolic left supraclavicular lymph node (suggestive of a metastatic disease). Owing to the high surgical risk inherent in a third surgical intervention, the French network for adrenal cancers (COMETE-Cancer) board proposed medical treatment with pegylated interferon alpha (Pegasys; 180 µg per week). After one year of treatment, a 30% decrease in urinary normetanephrine levels was observed. In addition, a marked morpho-metabolic regression of nearly all of the retroperitoneal lesions as well as of the left supraclavicular lymph node was evident. Unfortunately, the patient developed significant signs of drug intolerance, leading to dose tapering and treatment discontinuation. Conclusion: This is the first case of recurrent PGL that showed significant biological and imaging responses to medical treatment with pegylated interferon alpha. Further research on the potential usefulness of this therapeutic approach in patients with relapsing PGL or pheochromocytoma is warranted.

1 March 2015 in Diabetes & Metabolism
Verified
Journal Article
Closed access
PBP. Baltzinger
P. Baltzinger
TBThibault BAHOUGNE
Thibault BAHOUGNE
MGM. Greget
M. Greget
TDT. Degot
T. Degot
JRJ. Reeb
J. Reeb
LKL. Kessler
L. Kessler

Verified
Journal Article
Open access
PDF file
TBThibault BAHOUGNE
Thibault BAHOUGNE
PRPauline Romanet
Pauline Romanet
AMAmira Mohamed
Amira Mohamed
KCKevin Caselles
Kevin Caselles
TCThomas Cuny
Thomas Cuny
PNPatricia Niccoli
Patricia Niccoli
We report the case of a 21-year old woman presenting with high blood pressure and raised normetanephrine levels. Indium-111-pentetreotide single photon-emission computed tomography with computed tomography (SPECT/CT) and 2-deoxy-2-[fluorine-18]fluoro-d-glucose (FDG) positron emission tomography/computed tomography (PET/CT) imaging showing isolated tracer-uptake by a 2 cm tumor close to the costovertebral angle of the third thoracic vertebra. Thoracic surgery led to normalization of normetanephrine levels. Histological findings were consistent with the presence of a paraganglioma. Mutations in SDHA, SDHB, SDHC, SDHD, RET, SDHAF2, TMEM127, MAX, NF1, FH, MDH2, and EPAS1 were absent, but a heterozygous missense mutation, c.311G > T, was found in exon 1 of the von Hippel-Lindau gene, VHL, resulting in a glycine to valine substitution in the VHL protein at position 104, p.Gly104Val. This same mutation was found in both the mother and the 17-year old sister in whom a small retinal hemangioblastoma was also found. We diagnose an unusual functional mediastinal paraganglioma in this young patient with a germline VHL gene mutation, a mutation previously described as inducing polycythemia and/or pheochromocytoma but not paraganglioma or retinal hemangioblastoma.